www.fdanews.com/articles/148782-biosyent-pharma-signs-exclusive-licensing-and-distribution-agreement-for-two-new-drug-products

BioSyent Pharma Signs Exclusive Licensing and Distribution Agreement for Two New Drug Products

August 17, 2012

BioSyent announced that its subsidiary BioSyent Pharma has signed an exclusive licensing and distribution agreement with a European partner for two new products that will be marketed by its hospital products division. The products will be launched after Health Canada approval.
Equities